Network Pharmacology and Experimental Validation to Explore the Molecular Mechanisms of Compound Huangbai Liquid for the Treatment of Acne
Drug Design, Development and Therapy · 2023
DOI: 10.2147/dddt.s385208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Huifeng Di und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jinan City People's Hospital, Jinan, 271100, People's Republic of China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Acne Vulgaris. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jinan City People's Hospital, Jinan, 271100, People's Republic of China.
ORCID-Profile: Na Yi, Guangchen Wei
Zitieren
APA
Di, H., Liu, H., Xu, S., Yi, N., & Wei, G. (2023). Network Pharmacology and Experimental Validation to Explore the Molecular Mechanisms of Compound Huangbai Liquid for the Treatment of Acne. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s385208
Vancouver
Di H, Liu H, Xu S, Yi N, Wei G. Network Pharmacology and Experimental Validation to Explore the Molecular Mechanisms of Compound Huangbai Liquid for the Treatment of Acne. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s385208
BibTeX
@article{Di2023,
author = {Di, Huifeng and Liu, Hui and Xu, Shuna and Yi, Na and Wei, Guangchen},
title = {Network Pharmacology and Experimental Validation to Explore the Molecular Mechanisms of Compound Huangbai Liquid for the Treatment of Acne},
journal = {Drug Design, Development and Therapy},
year = {2023},
doi = {10.2147/dddt.s385208}
}
EUVIMED